NCI Launches Next Phase of Alliance for Nanotechnology in Cancer Program
The National Cancer Institute (NCI) has awarded five-year, multi-institution grants in continued support of its Alliance for Nanotechnology in Cancer program. The Alliance is engaged in efforts to leverage the specific advantages of nanotechnology to improve the way we diagnose, treat, and prevent cancer. Emory has received three awards for the second phase of this program. Of these awards, ACTSI investigator, Dong Shin, MD, is the PI for a Cancer Nanotechnology Platform Partnership. Read more…